Raymond Townsend, Director at Kindred Biosciences, Inc. (KIN), sold 2,670 shares at $9.45 ($25K) on 2018-03-16, disclosed to the SEC on 2018-03-19.
Scheduled sale ($25k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.45 | 1,760 | $17K | 65.9% |
| 2 | $9.45 | 910 | $9K | 34.1% |
| Total | $9.45 avg | 2,670 | $25K | 100% |
| Filing → |
| KIN | SELL | 2018-01-04 | $121K | — | Filing → |
| KIN | BUY | 2015-11-24 | $8K | — | Filing → |
| KIN | BUY | 2015-11-19 | $11K | — | Filing → |